1. Ames, R. P.: Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: possible alternative therapy. Amer. Heart J. 51, 632–638 (1983).
2. Ames, R. P., Hill, P.: Antihypertensive therapy and the risk of coronary heart disease. J. Cardiovasc. Pharmacol. 4 (Suppl. 2), 206–212 (1982).
3. Baum, T., Sybertz, E. J.: Antihypertensive actions of an isomer of labetalol and other vasodilator-ß-adrenoceptor blockers. Fed. Proc. 42, 176–181 (1983).
4. Berglund, G., Wilhelmsen, L., Sannerstedt, R., Hansson, L., Andersson, O., Sivertsson, R., Wedel, H., Wikstrand, J.: Coronary heart disease after treatment of hypertension. Lancet 1, 1–5 (1978).
5. Beermann, B., Groschinsky-Grind, M.: Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug. Europ. J. clin. Pharmacol. 13, 195–201 (1978).